Concepedia

Publication | Closed Access

Toll‐like receptor 2 agonist Pam3CSK4 enhances the induction of antigen‐specific tolerance via the sublingual route

DOI

100

Citations

32

References

2008

Year

Vincent Lombardi, Laurence Van Overtvelt, S. Horiot, Hélène Moussu, Henri Chabre, Anne Louise, A.M. Balazuc, Laurent Mascarell, Philippe Moingeon
Clinical & Experimental Allergy

Abstract

Pam3CSK4 induces Th1/regulatory T cell responses, and as such, is a valid candidate adjuvant for sublingual allergy vaccines.

References

YearCitations

Page 1